Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Investors bolster 908 Devices

by Marc S. Reisch
March 20, 2017 | A version of this story appeared in Volume 95, Issue 12

[+]Enlarge
Credit: 908 Devices
This molecular trap is at the heart of 908 Devices’ mass spectrometer.
A photo of the molecular trap at the heart of 908’s mass spectrometer.
Credit: 908 Devices
This molecular trap is at the heart of 908 Devices’ mass spectrometer.

908 Devices, a five-year-old maker of what it calls the first handheld, high-pressure mass spectrometer, has raised $20 million from investors including Saudi Aramco Energy Ventures, Schlumberger, and Tao Capital Partners. The funding will advance 908’s handheld device as well as a larger, rugged spectrometer for applied markets and its ZipChip, used in protein analysis. CEO Kevin J. Knopp says the funding will also enable the firm to “forge ahead into unchartered territories.”

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.